The DOI matches its Crossref record; 118 of the 119 references it cites were found in a registry or an index.
Development of selective androgen receptor modulators (SARMs)
Open accessAbstract
The Androgen Receptor (AR), a member of the steroid hormone receptor family, plays important roles in the physiology and pathology of diverse tissues. AR ligands, which include circulating testosterone and locally synthesized dihydrotestosterone, bind to and activate the AR to elicit their effects. Ubiquitous expression of the AR, metabolism and cross reactivity with other receptors limit broad therapeutic utilization of steroidal androgens. However, the discovery of selective androgen receptor modulators (SARMs) and other tissue-selective nuclear hormone receptor modulators that activate their cognate receptors in a tissue-selective manner provides an opportunity to promote the beneficial effects of androgens and other hormones in target tissues with greatly reduced unwanted side-effects. In the last two decades, significant resources have been dedicated to the discovery and biological characterization of SARMs in an effort to harness the untapped potential of the AR. SARMs have been proposed as treatments of choice for various diseases, including muscle-wasting, breast cancer, and osteoporosis. This review provides insight into the evolution of SARMs from proof-of-concept agents to the cusp of therapeutic use in less than two decades, while covering contemporary views of their mechanisms of action and therapeutic benefits.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Steiner introduced Enobosarm, Veru's investigational selective androgen receptor modulator (SARM) [30, 31].”
From Muscle Loss in Obesity Therapy as a Therapeutic Target: Trial Design and Endpoints for Regulatory Discussions (2025) · cites this paper as [30]
In the citing paper
“Putative mechanisms of SARM selectivity include tissue specific enzymes, modulated recruitment of coregulators and activation of unique subcellular signaling cascades are some of the putative mechanisms of SARM selectivity, 249 but more research is required to understand these mechanisms and then leverage these unique features to generative more efficacious therapeutics.”
From The role of the androgen receptor in the pathogenesis of obesity and its utility as a target for obesity treatments (2022) · cites this paper as [249]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Steroid and Thyroid Hormone Receptor Superfamily
Evans, R. M. (1988) · Science · doi:10.1126/science.3283939 · Cited by 7,394
Lehmann, B. D., Bauer, J. A., Chen, X., Sanders, M. E., Chakravarthy, A. B., Shyr, Y., & Pietenpol, J. A. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45014 · Cited by 5,592
MOLECULAR MECHANISMS OF ACTION OF STEROID/THYROID RECEPTOR SUPERFAMILY MEMBERS
Tsai, M., & O’Malley, B. W. (1994) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.63.070194.002315 · Cited by 2,887
Shiau, A. K., Barstad, D., Loria, P. M., Cheng, L., Kushner, P. J., Agard, D. A., & Greene, G. L. (1998) · Cell · doi:10.1016/s0092-8674(00)81717-1 · Cited by 2,759
A signature motif in transcriptional co-activators mediates binding to nuclear receptors
Heery, D. M., Kalkhoven, E., Hoare, S., & Parker, M. G. (1997) · Nature · doi:10.1038/42750 · Cited by 2,128
Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase
Kato, S., Endoh, H., Masuhiro, Y., Kitamoto, T., Uchiyama, S., Sasaki, H., Masushige, S., Gotoh, Y., Nishida, E., Kawashima, H., et al. (1995) · Science · doi:10.1126/science.270.5241.1491 · Cited by 1,964
Therapeutic Approaches to Bone Diseases
Rodan, G. A., & Martin, T. J. (2000) · Science · doi:10.1126/science.289.5484.1508 · Cited by 1,767
Population frequencies of inherited neuromuscular diseases—A world survey
Emery, A. E. H. (1991) · Neuromuscular Disorders · doi:10.1016/0960-8966(91)90039-u · Cited by 1,451
The Multifaceted Mechanisms of Estradiol and Estrogen Receptor Signaling
Hall, J. M., Couse, J. F., & Korach, K. S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.r100029200 · Cited by 1,202
Nongenotropic, Sex-Nonspecific Signaling through the Estrogen or Androgen Receptors
Kousteni, S., Bellido, T., Plotkin, L. I., O’Brien, C. A., Bodenner, D., Li, H., Han, K., Gregorio, G. B. D., Katzenellenbogen, J. A., Katzenellenbogen, B. S., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00268-9 · Cited by 1,163
Flagged first, then by citations
1 of the 119 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Ponnusamy, 2016, Tissue selective androgen receptor modulators (SARMs) increase pelvic floor muscle mass in ovariectomized mice, J. Cell Biochem.
Cited by
Sorted by citations
Items 201–253 of 253
LRH-1 is a novel regulator of neutrophil-driven immune responses within the tumor microenvironmentPreprint
Wang, Y., Duong, B., Keeley, S., Krawczynska, N., Bendre, S. V., Schane, C. P., Weisser, E., Cobo-Vuilleumier, N., Kockaya, L. I., Fei, Y.-F., et al. (2025) · bioRxiv · doi:10.1101/2025.09.16.676030
Efficacy and Safety of Targeting Androgen Receptor in Advanced Breast Cancer: A Systematic Review
Kassem, L. M. H., Shohdy, K. S., Makady, N. F., Salem, D. S., Ebrahim, N., & Aldaly, M. (2018) · Current Cancer Therapy Reviews · doi:10.2174/1573394714666180821145032
Androgen receptor expression and steroid action in bone
Krishnan, V. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814841-9.00041-5
Immunological, vascular and metabolic actions of androgens
Rodriguez, M. L. (2020)
Liao, J.-G., & Pan, W. (2020) · International Journal of Sciences · doi:10.18483/ijsci.2303
Androgen Receptors in the Pathology of Disease
Leung, J. K., Tien, A. H., & Sadar, M. D. (2021) · Springer eBooks · doi:10.1007/978-3-030-78315-0_16
Hu, T., Liu, Y., Zhao, G., Wang, S., & Long, M. (2021) · Research Square · doi:10.21203/rs.3.rs-958949/v1
Modulation of the Androgen Receptor Axis
Mohler, M. L., & Dalton, J. T. (2021) · Wiley eBooks · doi:10.1002/0471266949.bmc055.pub2
Self-citationGennari, L., Bandeira, L., Costa, A. G., Cusano, N. E., Silva, B. C. C., & Bilezikian, J. P. (2022) · Springer eBooks · doi:10.1007/978-3-030-90684-9_25
Hu, T., Liu, Y., Zhao, G., Wang, S., & Long, M. (2021) · Research Square · doi:10.21203/rs.3.rs-958949/v2
Furman, B. L. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.98042-5
Zajac, J. D., Seeman, E., Russell, N., Ramchand, S. K., Bretherton, I., Grossmann, M., & Davey, R. A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.11263-2
Hu, T., Liu, Y., Zhao, G., Wang, S., & Long, M. (2022) · Research Square · doi:10.21203/rs.3.rs-958949/v3
Ostarine avoids masseter atrophy caused by changes in the diet consistency
Shindo, J. V. T. C. (2022) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.25.2022.tde-01092022-090404
Carstens, J. C. (2022) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-9446
Gois, S. M. S., Borges, T. B. S., Sandes, M. N. S., & de Oliveira, L. T. S. (2022) · Revista Ibero-Americana de Humanidades, Ciências e Educação · doi:10.51891/rease.v8i11.7956
Benefits of Testosterone Replacement and Methods of Substitution
Ho, K. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.109345
Saúde e perfeição: Entre a utopia e a realidade
Castro, L. H. A. (2023) · doi:10.22533/at.ed.106233103
de Freitas, S. S., da Silva, W. L. S., da Costa, R. D. S., Paulino, R. O., Silva, W. R. D. S., Silva, W. N. D. S., Avelino, C. F., da Silva, A. M. S., de Souza, C. L. F., Ferreira, M. E. M., et al. (2023) · doi:10.22533/at.ed.1062331035
ESTABELECENDO MECANISMOS E DESVENDANDO O PAPEL DO GENE IGF-1 NA NEOPLASIA MAMÁRIA: REVISÃO NARRATIVA
de Arruda, G. M., da Silva, L. O., Teixeira, G. D., Braga, I. R. C., Sousa, A. R. M., Silva, F. Í. B. E., Siqueira, S. S. S. D. S., Teixeira, L. P. R., Costa, J. J. N., Noronha, E. C., et al. (2023) · doi:10.22533/at.ed.1062331038
O ENSINO TRANSVERSAL DE EMERGÊNCIA NOS CURSOS DE MEDICINA DO BRASIL: UMA REVISÃO DA LITERATURA
Santiago, T. C., & Novais, T. S. (2023) · doi:10.22533/at.ed.1062331031
PERSONAL TRAINER, QUEM É ESSE PROFISSIONAL?
Rangel, E. C., & Viana, R. D. M. (2023) · doi:10.22533/at.ed.1062331039
Cassola, T. P., Tier, C. G., Lana, L. D., dos Santos, A. O., Lira, L. G., da Cruz, M. D. R., da Silva, T. R. F., Carrera, L., Aguiar, E. D. S. R., de Moura, C. B. D. M., et al. (2023) · doi:10.22533/at.ed.1062331034
Ostafin, K., Edyko, K., Petryla, P., Minkner, M., Bieńkowski, B., Feja, K., Suwała, Z., REKTOR, N., Łuczak, E., & Marchewka, U. (2023) · Journal of Education Health and Sport · doi:10.12775/jehs.2023.45.01.030
Androgen Receptor Signaling: A Central and Evolving Theme in Prostate Cancer Treatment
Banerjee, P. P., & Srivastava, S. K. (2023) · Springer eBooks · doi:10.1007/978-981-99-2196-6_24-1
Kim, H., Seo, Y.-M., Lee, S., Kang, D., & Kim, C. (2023) · Urology Research and Practice · doi:10.5152/tud.2023.23065
Gudermann, T. W., Storch, U., & Boekhoff, I. (2024) · Springer eBooks · doi:10.1007/978-3-662-65517-7_16
Androgen Receptor Signaling: A Central and Evolving Theme in Prostate Cancer Treatment
Banerjee, P. P., & Srivastava, S. K. (2024) · Springer eBooks · doi:10.1007/978-981-99-6263-1_24 · Cited by 1
Yavuz, M., & Demircan, T. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.05.05.652263
Skeletal muscle adaptations to spaceflight: mechanisms and countermeasures
Kamal, K. Y., Trombetta-Lima, M., Lam, K., Davis, K., Jorgensen, B., Thomsen, C., Abdalla, A., Lawler, J. M., & Selsby, J. T. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-32904-3.00015-7
Selective Androgen Receptor Modulators in Women: What Do We Know, and What Is Still Missing
Vasilev, V., Georgieva, K. N., Kraeva, M. I., Ardasheva, R., Etova, R., & Boyadjiev, N. (2026) · Life · doi:10.3390/life16020359
Joly, M., Bizec, B. L., Monteau, F., Garcia, P., Ndiaye, M. M., Bailly‐Chouriberry, L., & Dervilly, G. (2026) · Food Additives & Contaminants Part A · doi:10.1080/19440049.2026.2628928
Gadallah, A. I., Abdelhaffez, A., Hussein, O. A., Sayed, S. A., Abdelhakiem, M. A. H., & El-Mottaleb, N. A. A. (2026) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2025-0063
Malnutrition and Sarcopenia in Liver Disease
Sharma, S., Goyal, G., & Sooch, J. (2025) · Springer eBooks · doi:10.1007/978-3-031-32047-7_140-1
Correction of male hypogonadism caused by anabolic steroid use
Gaidaichuk, K. E., Rozhivanov, R. V., Романовна, Р. Е., Andreeva, E. N., Mel'nichenko, G. A., & Mokrysheva, N. G. (2026) · Bulletin of Reproductive Health · doi:10.14341/brh12784
Yasin, J. A., Alkuttob, L. A., Adwan, S., Abdulla, M., Mansour, A., Alsafadi, D. B., Odat, R., & Ahram, M. (2026) · Research Square · doi:10.21203/rs.3.rs-9954513/v1
Mihalev, K., Iliev, I., Agova, N. V., Toshev, N., & Georgieva, S. F. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27135765
Nguyen, T. H., Nguyen, P. L. N., Nguyen, H. T. T., Nguyen, N. T., Danh, N. T., Hua, D. N. A., & Tran, V. D. (2026) · Journal of Natural Remedies · doi:10.18311/jnr/2026/48963
S4 Induces Apoptosis, Cell Cycle Arrest, and Metabolic Alterations in Breast Cancer Cells
Yavuz, M., & Demircan, T. (2026) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/0118715206494213260708101802
Targeting skeletal muscle wasting: emerging therapeutics and translational challenges
Roberts, B. M. (2026) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2026.131001
A TERRA-NONO axis drives fibroblast reprogramming in cancer
Cicco, E. D., Isma, J., Sol, S., Restivo, G., Mazzeo, L., Katarkar, A., Goruppi, S., White, J. R., Hafner, J., Neel, V., et al. (2026) · Science Advances · doi:10.1126/sciadv.aed3358
LRH-1 is a novel regulator of neutrophil-driven immune responses within the tumor microenvironment
Wang, Y., Duong, B., Keeley, S., Krawczyńska, N., Bendre, S. V., Schane, C. P., Pradeep, D., Rodriguez-Casiano, D., Weisser, E., Vuilleumier, N. C., et al. (2026) · Cancer Letters · doi:10.1016/j.canlet.2026.218910 · Cited by 1
Adolf, J., & Enev, G. (2026) · Drug Testing and Analysis · doi:10.1002/dta.70174
Schumacher, M., & Ghoumari, A. M. (2026) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2026.101293
BindingDB Entry 50016950: Therapeutic Strategies to Target the Androgen Receptor.
BindingDB (2023) · UC San Diego · doi:10.7270/q2j1076h
BindingDB Entry 50021145: Annual review of PROTAC degraders as anticancer agents in 2022.
BindingDB (2025) · UC San Diego · doi:10.7270/q2805771
Metadata
- Authors
- Narayanan, R., Coss, C. C., & Dalton, J. T.
- Affiliations
- University of Tennessee Health Science Center (US)
- The Ohio State University (US)
- University of Michigan (US)
- Corresponding author
- Dalton, James T.
- Venue
- Molecular and Cellular Endocrinology
- Publisher
- Elsevier BV
- Published
- 2018-04
- Volume
- 465
- Pages
- 134-142
- ISSN
- 0303-7207 (ISSN-L)
- PMC
- PMC5896569
- OpenAlex
- W2625829876
- Cited by
- 251
- References
- 119
- Citations by year
- 2026: 17 · 2025: 22 · 2024: 19 · 2023: 38 · 2022: 42 · 2021: 37 · 2020: 27 · 2019: 24 · 2018: 21
- FWCI
- 3.00
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Molecular and Cellular Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (K12CA133250)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Prostate Cancer Treatment and Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Keywords
- selective androgen receptor modulators, androgen receptor, testosterone, dihydrotestosterone, muscle atrophy, breast cancer, osteoporosis, mechanism of action, drug development
- MeSH terms
- Androgens, Animals, Humans, Models, Biological, Organ Specificity, Receptors, Androgen
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
